Prof Paul Townsend

Associate Dean and Professor

Full contact details
View graph of relations

Overview

I am a fully tenured Principal Investigator, Associate Dean of Business Engagement, co-Director of Manchester Centre for Cellular Metabolism, I am Professor of Molecular Cell Biology, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester. I act as one of the key university conduits for the CRUK Manchester Institute, Medicines Discovery Catapult and I am the Industry Lead for thr Manchester BRC and Manchester academic lead for Singapore. I am also a PI in the Manchester Cancer Research Centre and hold adjunct professorships in Athens and Singapore.. 

After reading for my doctorate at the Imperial Cancer Research Fund (now CRUK) in London (1997), I undertook post-doctoral research at Imperial College London, Southampton and University College, London with associated research spells in Michigan and Frankfurt. I have helped lead a transformational change in an applied research focus and activity in Manchester, engendering a culture of multiple stakeholders including the NHS, academics, industry, innovative funding agencies, the public and patients. One key output during my time in Manchester is an enhancement of the biomedical industrial and basic research partnerships portfolio which has helped generate successful MRC and SBRI/ NIHR funding programmes. Moreover, applied-industrial research ipact and income has moved from an FEC deficit to one which is pragmantic and cost effective for the faculty.

External positions

Co-founder, PRECignature Biotechnology

2018 → …

Co-founder, Pentagon Biotechnology

2018 → …

NED and SAB, DeepMed IO Limited

2017 → …

Advisor, Inspiral Biomedical Limited

2016 → …

Honorary Professor, Department of Histology & Embryology, University of Athens

Sep 2015 → …

Adjunct Professor, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR)

Aug 2015 → …

Academic Lead, Medicines Discovery Catapult Ltd

Jul 2015 → …

NED and SAB, Aptamer Group Ltd

2011 → …

Co-founder, Karus Therapeutics Ltd

Jul 2005 → …

Areas of expertise

  • QP Physiology - Cancer Biology, Cancer, Proteomics, Biomarkers, Diagnostics, Drug discovery and validation, Wellness, Systems Health
  • R Medicine (General) - Disease, Cardiovascular, Skeletal Biology, Stress Biology, Apoptosis and cell survival

Education / academic qualifications

  • 1993 - Bachelor of Science, Molecular Cell Biology, University of York (1990 - 1993)
  • Head Start Leadership Programme, Masters level, The University of Manchester (2013 - 2014)
  • Professional Certificate in Academic Performance, University of Southampton (2005 - 2006)
  • Doctor of Philosophy, Biochemistry - Imperial Cancer Research Fund (CRUK) (1993 - 1997)

Related information